Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of core cuprotosis-correlated biomarkers in abdominal aortic aneurysm immune microenvironment based on bioinformatics. | Front Immunol | 2023 | 37138870 | PubTator, text mining | PubMed |
| The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma. | Front Pharmacol | 2023 | 37138850 | PubTator, text mining | PubMed |
| From disobedience to struggle for adaptation: nursing students' experiences of attending the clinical learning environment during Covid-19 pandemic. | BMC Psychiatry | 2023 | 37131134 | PubTator, text mining | PubMed |
| Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan. | J Neuromuscul Dis | 2023 | 37125562 | PubTator, text mining | PubMed |
| Copper-binding proteins genes set predicting the overall survival and immune infiltration in hepatocellular carcinoma by bioinformatic analysis. | Biochem Biophys Rep | 2023 | 37125079 | PubTator, text mining | PubMed |
| LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer. | Front Genet | 2023 | 37124623 | PubTator, text mining | PubMed |
| Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma. | Front Genet | 2023 | 37124619 | PubTator, text mining | PubMed |
| Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma. | Mediators Inflamm | 2023 | 37124062 | PubTator, text mining | PubMed |
| Neonatal presentation of occipital horn syndrome caused by a ATP7A missense variant. | J Inherit Metab Dis | 2023 | 37114831 | PubTator, text mining | PubMed |
| Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma. | Front Pharmacol | 2023 | 37113755 | PubTator, text mining | PubMed |
| MNK Proteins as Therapeutic Targets in Leukemia. | Onco Targets Ther | 2023 | 37113687 | PubTator, text mining | PubMed |
| An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. | Pharmaceutics | 2023 | 37111758 | PubTator, text mining | PubMed |
| Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. | Int J Mol Sci | 2023 | 37108749 | PubTator, text mining | PubMed |
| Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis. | Front Mol Biosci | 2023 | 37091865 | PubTator, text mining | PubMed |
| Revalidation and expanded description of Mustela aistoodonnivalis (Mustelidae: Carnivora) based on a multigene phylogeny and morphology. | Ecol Evol | 2023 | 37082328 | PubTator, text mining | PubMed |
| Significance of cuproptosis-related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach. | Thorac Cancer | 2023 | 37076991 | PubTator, text mining | PubMed |
| COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 | 37072858 | PubTator, text mining | PubMed |
| Pigmentation and TYRP1 expression are mediated by zinc through the early secretory pathway-resident ZNT proteins. | Commun Biol | 2023 | 37072620 | PubTator, text mining | PubMed |
| The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling. | J Cell Biol | 2023 | 37071417 | PubTator, text mining | PubMed |
| Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction. | Front Genet | 2023 | 37065492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=23